JAG Source IPA, LLC的动态

My main takeaways from another amazing Dermsquared #FallClinical: 1) The dermatology pipeline is immense. Numerous novels MoAs are incoming for #HidradenitisSuppurativa #AtopicDermatitis and #ChronicSpontaneousUrticaria. While big Pharma including most notably Sanofi Eli Lilly and Company AbbVie Incyte Johnson & Johnson Novartis and Takeda have many Ph2-Ph3 assets, a plethora of smaller biotech interests including, but certainly not limited, to Alumis Apogee Therapeutics Oruka Therapeutics Q32 Bio Inc. Celldex Therapeutics MoonLake Immunotherapeutics (NASDAQ: MLTX) AnaptysBio are also involved. 2) "The Year of the JAK" Since it may be a while until many of the these assets can make it to the finish line, we need to utilize what we have available right now for our patients (which is still pretty good!). I heard Dr. Theodore Rosen call this the "The Year of the JAK" and I couldn't agree more. Janus kinase inhibitors are being used more and more as dermatology providers come to the realization that these therapies can be used with a high degree of safety with proper patient selection and counseling. As these therapies get approved for more conditions of unmet need (i.e. Rinvoq in #vitiligo and #alopeciaareata, povorcitinib in #HS), our patients will expect us to be competent in prescribing these oral small molecules. 3) We are so blessed to be in dermatology. Not just dermatologists, but all of us including our industry colleagues, advanced practice providers, biologics coordinators, medical assistants, front office staff, and everyone else... our patients for the most part are doing well and on good therapies, and I've developed so many friendships across the dermatology ecosystem for which I'm very grateful.

?? Exciting news – our brand new Case Studies service is here! One of the biggest challenges we hear from physios is bridging the gap between theory and real-world practice. Knowing the research is one thing - but applying it confidently with patients in a busy clinic? That’s a whole different challenge. That’s why we’ve created Case Studies – a brand-new service designed to give clinicians real-world clinical insights from top experts. Every month, we’ll break down complex cases, walking clinicians through assessment, treatment, and decision-making, so they can sharpen their skills and feel more confident in the clinic. At Physio Network, we've always been about helping clinicians stay at the top of their game. With Case Studies, we’re taking that one step further - giving clinicians the tools to turn knowledge into action. A huge thank you to the world-leading experts we’re working with on this project. We couldn’t do it without you, and we’re incredibly excited to bring your knowledge, experience, and clinical reasoning to physios around the world. Learn more about Case Studies here - https://lnkd.in/greW3g5K Adam Johnson Charlie Clements Dr. Kieran Richardson

Check out this short video about the "Mom Rule" here at Caris.

THIS will change EVERYTHING about labor management

As a Clinical Advisory Board member for TailorCare, I'm excited to write that TailorCare has acquired RecoveryOne, marking a significant step forward in transforming musculoskeletal (MSK) care. By combining TC's patient care navigation expertise with RecoveryOne’s innovative virtual physical therapy delivery, TC is actively re-inventing quality MSK care.

NEW BLOG POST ALERT! "CenterPointe's mission, 'to help the people we serve get better, sooner, for longer,' is a testament to our unwavering commitment. This commitment has led to the development of the CenterPointe Model of Care and its five foundational pillars. These pillars, the guiding principles of our services, ensure a personalized approach to each individual's unique needs and circumstances." Visit our website to read more about CenterPointe's Model of Care from our Chief Clinical Officer, Dr. Ryan Carruthers. https://ow.ly/nMmR50REPnJ

Clinical trial diversity is key to success on #raredisease #drugdevelopment. How to improve it and ensure adequate representation of the full patient population remains a challenge. What a stellar line-up of speakers to discuss this central issues!

Today we’re celebrating #WorldClinicalTrialsDay! It’s been a remarkable 277 years since James Lind (a ship’s surgeon in the British Royal Navy) conducted the first-ever randomised clinical trial and discovered that citrus fruits could help cure scurvy. As a company dedicated to maximising the success of clinical trials, we understand the profound impact they can have on patients worldwide. Whilst we have come a long way, there's still immense potential to make clinical trials even more effective and get treatments to patients much faster. That’s why we’d like to join our Head of Clinical Development, @Geoff Brooks, in saying a special thank you to: - The researchers who tirelessly design and conduct these trials. - The patients who volunteer their time and participation. - The skilled healthcare professionals who ensure patient safety and data integrity. - And everyone else involved in bringing new medical solutions to market. As for our Weatherden colleagues, your combined 900+ years of experience in clinical development is instrumental in designing effective trials, and getting effective solutions to patients faster. Thank you for helping us on our mission to give every drug its best chance of success! Learn all about Clinical Trials Day here: https://lnkd.in/e9r9k5Wu #CTD2024 #ClinicalTrialsDay #ClinicalDevelopment #DrugDevelopment

I love this! Our clients experience a significant reduction in the time spent on clinical documentation with Microsoft's AI-powered productivity and dictation tool. It's increasingly popular among both small practices and hospitals in New Zealand and Australia. #medical #clinicaloperations #healthtech #healthAI #healthcaremanagement

We love this! Our clients experience a significant reduction in the time spent on clinical documentation with Microsoft's AI-powered productivity and dictation tool. It's increasingly popular among both small practices and hospitals in New Zealand and Australia. #medical #clinicaloperations #healthtech #healthAI #healthcaremanagement